Product Information
VALSARTAN 40 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0991 per EA under NDC 55111073190. Its NADAC has been published 217 times since Apr 6, 2022.
FDA first approved this application on Oct 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Valsartan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111073190
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA201618FDA Approved
10/5/2021
TE Code
AB
On Market Since
3/30/2018
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 40 MG TABLET has been published 217 times since Apr 6, 2022, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0991 per EA |
|---|---|
| All-time high | $0.2111 (Jun 15, 2022) |
| All-time low | $0.0991 (May 20, 2026) |
| 52-week high | $0.1286 |
| 52-week low | $0.0991 |
| Median price | $0.1369 |
| Average price | $0.1410 |
| Largest weekly change | +45.1% (Aug 21, 2024) |
| Weeks tracked | 217 |
| Tracking since | Apr 6, 2022 |
1W
N/A
1M
N/A
3M
0.0%
6M
-11.0%
1Y
-23.0%
3Y
-37.6%
5Y
N/A
All
-49.1%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALSARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 40 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0991 per EA (NDC 55111073190), effective May 27, 2026.
How has the price of VALSARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 40 MG TABLET has declined 49.1%. It has been tracked across 217 weekly CMS publications since Apr 6, 2022.
What are the highest and lowest recorded NADAC prices for VALSARTAN 40 MG TABLET?
Since Apr 6, 2022, the NADAC for VALSARTAN 40 MG TABLET has ranged from a low of $0.0991 (May 20, 2026) to a high of $0.2111 (Jun 15, 2022), with a median of $0.1369 per EA.
Are there cheaper alternatives to VALSARTAN 40 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALSARTAN 40 MG TABLET, is $0.0973 per EA — about 2% below VALSARTAN 40 MG TABLET.
Who manufactures VALSARTAN 40 MG TABLET?
VALSARTAN 40 MG TABLET (NDC 55111073190) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.